← Back to Search

Procedure

CT-guided stereotactic adaptive radiotherapy for Solid Malignancies

N/A
Waitlist Available
Led By Lauren E Henke, M.D., M.S.C.I.
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through completion of treatment (estimated to be 2 weeks)
Awards & highlights

Study Summary

This trial is testing a new system that uses CT-guided radiotherapy with a surface guidance beam-gating system to manage respiratory motion during treatment. The new system is being tested to see if it is feasible and safe to use with upper abdominal or lower thoracic malignancies.

Eligible Conditions
  • Solid Malignancies

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through completion of treatment (estimated to be 2 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and through completion of treatment (estimated to be 2 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of Scheduled Treatment Fractions Delivered Successfully Using the Surface Guidance System

Trial Design

1Treatment groups
Experimental Treatment
Group I: CT-guided stereotactic adaptive radiotherapyExperimental Treatment2 Interventions
-Radiotherapy will consist of stereotactic body therapy, to be given over five fractions, delivered once daily or once every other day for a period of one to two weeks, for a total of five treatments.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CT-guided stereotactic adaptive radiotherapy
2021
N/A
~10
ETHOS
2021
N/A
~10

Find a Location

Who is running the clinical trial?

Varian Medical SystemsIndustry Sponsor
58 Previous Clinical Trials
3,729 Total Patients Enrolled
Washington University School of MedicineLead Sponsor
1,935 Previous Clinical Trials
2,299,797 Total Patients Enrolled
1 Trials studying Solid Malignancies
12 Patients Enrolled for Solid Malignancies
Lauren E Henke, M.D., M.S.C.I.Principal InvestigatorWashington University School of Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Novel Optical Surface Image Guidance System for Beam-Gated Online Adaptive SBRT Delivery in Mobile Lower Lung and Upper Abdominal Malignancies
2021. "Novel Optical Surface Image Guidance System for Beam-Gated Online Adaptive SBRT Delivery in Mobile Lower Lung and Upper Abdominal Malignancies". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05030454.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top